Doxorubicin also increased expression of hypertrophy and heart failure markers β-MHC, atrial natriuretic peptide (ANP), and troponin T as well as the oxidative stress marker MDA via a RGS6-dependent mechanism (Fig. 8A). The gene discussed is RGS6; the disease is heart failure.